STLNW — Starling Oncology, Inc.

Nasdaq · Health Care · Health Care Providers & Services · CIK 1799191 ·
Last close
Market Cap
52W High
52W Low
ADV30
Next earnings

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Dec 2024 99,901,000 128,120,000 -13,853,000 -16,113,000 172,717,000 169,128,000
Dec 2023 82,035,000 111,915,000 -13,925,000 -17,419,000 209,240,000 152,215,000
Dec 2022 60,921,000 79,567,000 -18,304,000 -5,453,000 261,665,000 138,490,000

Annual Trend (SEC EDGAR, last 2y)

Revenues vs Net Income (last 2y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2024 393,412,000 -60,118,000 -64,663,000 172,717,000 169,128,000
Dec 2023 324,239,000 -77,018,000 -83,068,000 209,240,000 152,215,000

TTM Snapshot

Revenues TTM
$363,872,000
NetIncome TTM
$-67,064,000
OpCashFlow TTM
$0
Assets (Latest)
$172,717,000
Forward EPS

Peers — same industry

TickerNameMarket CapLastDaily %
HCA HCA Healthcare, Inc. $89.77B $404.68
NTRA Natera, Inc. $44.67B $309.93
DGX QUEST DIAGNOSTICS INC $25.87B $234.40
LH LABCORP HOLDINGS INC. $25.80B $318.13
THC TENET HEALTHCARE CORP $21.57B $267.90

News headlines (Yahoo Finance, 1h cache)

Starling Oncology Reports Second Quarter 2026 Financial Results and Updates Full-Year 2026 Guidance
2026-08-06 20:14 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.